A Comparison Study of Persistence of UPadacitinib vs. TNF-inhibitoRs In a German Real-world SettING
Study Identifier
P25-188
CT.gov Identifier
EudraCT Identifier
Not available
EUCTIS ID
Not available
For general inquiries, please contact
Recruiting
Study Details
Medical Condition
Study Drug
N/A
Phase
N/A
Sex
Female & Male
Age
18+ years
Protocol Summary
This study will compare the retention rates for UPA vs. TNFi treatment in adult participants with moderate to severe active RA per local label and according to local standard of care
This is a mono-country, prospective, multi-center observational study in patients with moderate to severe active RA receiving UPA or TNFi therapy. Around 678 participants will be enrolled in approximately 80 sites in Germany.
Study recruitment will last approximately 24 months, and the study participation time will be up to 24 months, for a total study duration of approximately 48 months.
Study Locations
Location
Status
Location
Gemeinschaftspraxis Innere Medizin/Rheumatologie /ID# 278584
Freiburg im Breisgau, Baden-Wurttemberg, Germany, 79098
Status
Recruiting
Location
Rheumapraxis Heidelberg /ID# 276475
Heidelberg, Baden-Wurttemberg, Germany, 69120
Status
Recruiting
Location
Rheumapraxis Haas Tübingen /ID# 275536
Tübingen, Baden-Wurttemberg, Germany, 72072
Status
Recruiting
Location
Rheumapraxis Ulm Dr. med. Nadia Rinaldi /ID# 276293
Ulm, Baden-Wurttemberg, Germany, 89073
Status
Recruiting
Location
Dr. Med. Thomas Marycz /ID# 274646
Amberg, Bavaria, Germany, 92224
Status
Recruiting
Location
Rheumapraxis Am Webereck /ID# 274412
Augsburg, Bavaria, Germany, 86157
Status
Recruiting
Showing {first} - {last} of {total} Results